Gastric Cancer

Adding Onartuzumab to Chemo Not Effective for HER2-, MET+ Gastroesophageal Adenocarcinoma

Adding Onartuzumab to Chemo Not Effective for HER2-, MET+ Gastroesophageal Adenocarcinoma

By

Adding the mesenchymal-epithelial transition (MET) antibody onartuzumab did not significantly improve clinical outcomes.

Helicobacter Pylori and Cancer Risk (Fact Sheet)

Helicobacter Pylori and Cancer Risk (Fact Sheet)

This fact sheet explores the links, both negative and positive, that Helicobacter pylori may have with gastric and other cancer types.

No Benefit for Chemoradiotherapy vs Chemotherapy After Resectable Gastric Cancer

No Benefit for Chemoradiotherapy vs Chemotherapy After Resectable Gastric Cancer

By

First results from the phase 3 CRITICS study found no significant difference in overall survival between postoperative chemotherapy and chemoradiotherapy in patients with resectable gastric cancer, according to a study presented at the ASCO 2016 Annual Meeting.

B-DOC Regimen Plus Maintenance Feasible for Advanced Gastric Cancer

B-DOC Regimen Plus Maintenance Feasible for Advanced Gastric Cancer

By

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine (B-DOC) plus maintenance therapy was feasible and active.

Chemosensory Changes Influence Food Preferences

Chemosensory Changes Influence Food Preferences

By

Chemosensory and food-related changes significantly impacted food preferences and had practical and social consequences.

Current Targeted Therapies May Be Effective in Gastric Cancer

By

Certain drugs currently used to treat breast, ovarian, and pancreatic cancers could also be used to treat certain gastric cancers with a particular genomic molecular fingerprint.

Adding Panitumumab to Chemo Does Not Prolong Survival in Wild-Type Biliary Tract Cancer

Adding Panitumumab to Chemo Does Not Prolong Survival in Wild-Type Biliary Tract Cancer

By

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer.

Eradicating H. pylori may reduce stomach cancer risk

Eradicating H. pylori may reduce stomach cancer risk

The heliobacter pylori bacterium is the main cause of stomach ulcers, and it also a known risk factor for non-cardia gastric cancer.

Pembrolizumab Active in Advanced Gastric Cancer

Pembrolizumab Active in Advanced Gastric Cancer

By

The anti-PD-1 monoclonal antibody, pembrolizumab (MK-3475), demonstrated promising antitumor activity in advanced gastric cancer, according to a study presented at the 2015 ASCO Annual Meeting.

Nutrition support may prolong survival in high risk patients with gastric cancer

Nutrition support may prolong survival in high risk patients with gastric cancer

Nutrition support might be helpful to improve the prognosis of patients with stage IV gastric cancer.

Precise risk assessment for gastric and breast cancers among CDH1 gene mutation carriers may improve genetic counseling

By

More exacting estimates of age-associated risks of gastric and breast cancer were derived for carriers of the CDH1 gene mutation, a cancer-predisposing gene in families meeting criteria for clinically defined hereditary diffuse gastric cancer.

Botox may be safe and effective for the treatment of gastric cancer

Botox may be safe and effective for the treatment of gastric cancer

Researchers found that the vagal nerve contributes to the growth of gastric tumors through the release of a neurotransmitter.

Daily dose of aspirin significant lowers cancer risk

Daily dose of aspirin significant lowers cancer risk

In a recent study, researchers found that by taking a daily aspirin, the incidence of gastrointestinal cancers is reduced, as well as a reduction in cancer-specific mortality.

Cancer-specific stem cell identified for gastric cancer

By

Scientists have identified the cancer-specific stem cell that causes gastric cancer. This discovery opens up the possibility of developing new drugs for the treatment of this disease and other types of cancers.

Esophageal and gastric cancers linked to teen weight

Esophageal and gastric cancers linked to teen weight

Adolescents' weight and socioeconomic status (SES) may affect their subsequent risk of developing esophageal and gastric cancer, according to a study.

Ramucirumab prolongs survival in advanced gastric cancer

By

An investigational drug improved median survival while reducing risk of disease progression or death in persons with metastatic gastric cancer participating in the phase III REGARD trial.

Hodgkin treatment raises risk for stomach cancer

By

Survivors of Hodgkin lymphoma who received subdiaphragmatic radiotherapy had dose-dependent increased risk for stomach cancer, researchers discovered.

Three subtypes of gastric cancer suggest different treatments

By

Stomach cancer, one of the leading causes of cancer death worldwide, actually falls into three broad subtypes that respond differently to currently available therapies, according to new research.

Dietary fiber intake can reduce gastric cancer risk

Dietary fiber intake can reduce gastric cancer risk

Meta-analysis shows lower odds of gastric cancer for highest versus lowest intake of dietary fiber.

Survival improved by surgery and radiation for patients with metastatic gastric cancer

By

Recently, researchers analyzed metastatic gastric cancer cases from the SEER database to help determine which treatment options offer the best survival possibilities.

Surgery plus radiation boosts survival in metastatic gastric cancer

Persons with metastatic gastric cancer who had both surgery and radiation lived longer than patients who underwent one or neither treatment.

ONS Connections: Participatory nutrition education effective for patients with gastrectomy

By

A nutritional education program for patients with gastrectomy improved knowledge, oral intake, adherence to diet guidelines, and patient satisfaction compared with patients who received usual nutrition education.

Diagnosis delayed for certain cancers and certain patients

A large UK study found a wide variation between cancer types in patients who had visited their general practitioner 3 or more times before cancer diagnosis.

Adjuvant radiochemotherapy has lasting benefit in gastric cancer

Adjuvant radiochemotherapy has lasting benefit in gastric cancer

Patients with gastric cancer who undergo resection show survival benefit 10 years later.

More evidence shows aspirin might stave off cancer

By

Results from three new studies are consistent with earlier findings that aspirin can reduce cancer risk and, in some cases, metastasis.

Regular Aspirin Use Can Lower Cancer Risk, Studies Confirm

Regular Aspirin Use Can Lower Cancer Risk, Studies Confirm

Aspirin use lowers the risk of esophageal, gastric, biliary, and breast cancer and reduces distant metastases.

Lung, pancreas only major cancers projected to have higher mortality in Europe in 2012

With the exception of lung cancer in women and pancreatic cancer, mortality from major cancers is expected to decline in the European Union in 2012.

Children Now Eligible for Screening Test for Bacterium

Children Now Eligible for Screening Test for Bacterium

The FDA has expanded approval to children for a breath test that screens for Helicobacter pylori, a cause of ulcers, gastritis, and certain cancers.

Exercise improves life after cancer treatment

By

Physical activity was associated with important positive effects on physical functions and quality of life in persons who had completed their treatment for cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs